Samrat Pharmachem

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue80.0462.0982.9881.4170.66
Expenses79.8161.9581.6078.5967.15
EBITDA0.530.531.653.173.85
EBIT0.370.371.503.013.69
Profit Before Tax0.240.141.392.823.52
Net Profit-0.190.341.402.072.66
Financial Ratios
Operating Profit Margin0.66%0.86%2.00%3.92%5.49%
Net Profit Margin-0.24%0.55%1.69%2.56%3.79%
Earning Per Share (Diluted)-0.611.114.526.688.61
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ